International Clinical Trial: A Phase 1b Study to Assess the Safety and Tolerability of AB126 Neural Exosomes in Patients With Moderate to Severe Acute Ischemic Stroke

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07813130) titled 'A Phase 1b Study to Assess the Safety and Tolerability of AB126 Neural Exosomes in Patients With Moderate to Severe Acute Ischemic Stroke' on Sept. 2.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Aruna Bio, Inc.

Condition: Acute Ischemic Stroke

Intervention: Biological: AB126 Neural Exosomes Intravenous Injection

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: October 2026

Target Sample Size...